Literature DB >> 18980784

RNA polymerases I and III, non-coding RNAs and cancer.

Robert J White1.   

Abstract

Oncogenically transformed cells overexpress the non-coding RNAs, such as pre-ribosomal RNA (rRNA) and transfer RNA (tRNA), which are produced by RNA polymerases (Pols) I and III. Recent results indicate that levels of pre-rRNA have prognostic value and that a tRNA has oncogenic potential. Transcription by Pols I and III is restrained in healthy cells by the tumour suppressors RB, p53, ARF and PTEN. Such restraints are compromised during cell transformation and the problem is accentuated by oncogene products, such as c-Myc, that stimulate the output of Pol I and Pol III. The resultant increases in rRNA and tRNA expression might promote the generation of cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18980784     DOI: 10.1016/j.tig.2008.10.003

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  99 in total

1.  Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer.

Authors:  Robert Cornelison; Zachary C Dobbin; Ashwini A Katre; Dae Hoon Jeong; Yinfeng Zhang; Dongquan Chen; Yuliya Petrova; Danielle C Llaneza; Adam D Steg; Laura Parsons; David A Schneider; Charles N Landen
Journal:  Clin Cancer Res       Date:  2017-08-04       Impact factor: 12.531

Review 2.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

Review 3.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

4.  Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA.

Authors:  Le Xuan Truong Nguyen; Beverly S Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

5.  Transcription by the multifunctional RNA polymerase I in Trypanosoma brucei functions independently of RPB7.

Authors:  Sung Hee Park; Tu N Nguyen; Justin K Kirkham; Ju Huck Lee; Arthur Günzl
Journal:  Mol Biochem Parasitol       Date:  2011-07-23       Impact factor: 1.759

6.  Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer.

Authors:  John T Cunningham; Melissa V Moreno; Alessia Lodi; Sabrina M Ronen; Davide Ruggero
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

7.  Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.

Authors:  Jessica Finlay-Schultz; Austin E Gillen; Heather M Brechbuhl; Joshua J Ivie; Shawna B Matthews; Britta M Jacobsen; David L Bentley; Peter Kabos; Carol A Sartorius
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

Review 8.  Contributions of in vitro transcription to the understanding of human RNA polymerase III transcription.

Authors:  Hélène Dumay-Odelot; Stéphanie Durrieu-Gaillard; Leyla El Ayoubi; Camila Parrot; Martin Teichmann
Journal:  Transcription       Date:  2014

Review 9.  Controlling translation via modulation of tRNA levels.

Authors:  Jeremy E Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-04-28       Impact factor: 9.957

Review 10.  Dysregulation of the basal RNA polymerase transcription apparatus in cancer.

Authors:  Megan J Bywater; Richard B Pearson; Grant A McArthur; Ross D Hannan
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.